Ultra-Large Volume Wearable Injectors Market by Product Type (Electromechanical Wearable Injector, and Others) and Application (Diabetes, Cancer, and Others): Global Opportunity Analysis and Industry Forecast, 2019–2026
The ultra large volume wearable injectors market accounted for $1,408 million in 2018, and is expected to reach $4,066 million by 2026, registering a CAGR of 14.2% from 2019 to 2026.
Ultra large volume wearable injectors are devices specially designed to stick to the body. These devices work on different mechanisms to deliver drug to the patient through subcutaneous route over an extended period of time. Furthermore, these devices have drug reservoirs that can store drugs solution of 2ml or more then 2ml. For instance, these devices function on mechanisms such as electromechanical, mechanical, and others. In addition, the electromechanical devices work with the help of electrical motor, which is responsible to build pressure for drug delivery. However, mechanical devices use osmosis to deliver the drug to the body of the patient. Furthermore, there are different benefits associated with the use of these devices. These include better patient compliance as this eliminates the need of frequent drug administration, easy ambulation as the patient is not tethered to an IV line, self-administration which lowers the frequency of healthcare professional visits, and others. In addition, these devices are used for the treatment of various chronic conditions such as cancer, diabetes, Parkinson’s diseases, and others.
The major factor that contributes toward the growth of the ultra large volume wearable injectors market include surge in prevalence of chronic disorders such as diabetes, cancer, and others. Furthermore, other factors such as benefits associated with the use of ultra large volume wearable injectors and rise in adoption of these devices across the globe fuel the growth of the market.
Moreover, surge in the demand of more advanced treatment options for chronic diseases such as diabetes contributes toward the growth of the market. In addition, increase in focus by key players toward launch of new products in the market has led to rise in collaborations within the market, which fuels the growth of the market. However, high price of ultra large volume wearable devices restrict the global ultra large volume wearable injectors market growth. In contradiction, presence of ultra large volume wearable devices in development phase, which are expected to be introduced during the forecast period is expected to provide lucrative opportunities for the players in the market.
The ultra large volume wearable injectors market is segmented on the basis of product type, application, and region to provide a detailed assessment of the market. By product type, the market is divided into electromechanical wearable injectors and others. By application, it is classified into diabetes, cancer and others. By region, the ultra large volume wearable injector market size is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).
Major players operating in the market include Amgen Inc., Becton, Dickinson And Company, CeQur SA, Enable Injections, Inc., Gerresheimer AG (Sensile Medical AG), Insulet Corporation, Medtronic plc., Tandem Diabetes Care, Inc., West Pharmaceutical Services, Inc., and Ypsomed Holding AG.
KEY BENEFITS FOR STAKEHOLDERS
Ultra large volume wearable injectors are devices specially designed to stick to the body. These devices work on different mechanisms to deliver drug to the patient through subcutaneous route over an extended period of time. Furthermore, these devices have drug reservoirs that can store drugs solution of 2ml or more then 2ml. For instance, these devices function on mechanisms such as electromechanical, mechanical, and others. In addition, the electromechanical devices work with the help of electrical motor, which is responsible to build pressure for drug delivery. However, mechanical devices use osmosis to deliver the drug to the body of the patient. Furthermore, there are different benefits associated with the use of these devices. These include better patient compliance as this eliminates the need of frequent drug administration, easy ambulation as the patient is not tethered to an IV line, self-administration which lowers the frequency of healthcare professional visits, and others. In addition, these devices are used for the treatment of various chronic conditions such as cancer, diabetes, Parkinson’s diseases, and others.
The major factor that contributes toward the growth of the ultra large volume wearable injectors market include surge in prevalence of chronic disorders such as diabetes, cancer, and others. Furthermore, other factors such as benefits associated with the use of ultra large volume wearable injectors and rise in adoption of these devices across the globe fuel the growth of the market.
Moreover, surge in the demand of more advanced treatment options for chronic diseases such as diabetes contributes toward the growth of the market. In addition, increase in focus by key players toward launch of new products in the market has led to rise in collaborations within the market, which fuels the growth of the market. However, high price of ultra large volume wearable devices restrict the global ultra large volume wearable injectors market growth. In contradiction, presence of ultra large volume wearable devices in development phase, which are expected to be introduced during the forecast period is expected to provide lucrative opportunities for the players in the market.
The ultra large volume wearable injectors market is segmented on the basis of product type, application, and region to provide a detailed assessment of the market. By product type, the market is divided into electromechanical wearable injectors and others. By application, it is classified into diabetes, cancer and others. By region, the ultra large volume wearable injector market size is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).
Major players operating in the market include Amgen Inc., Becton, Dickinson And Company, CeQur SA, Enable Injections, Inc., Gerresheimer AG (Sensile Medical AG), Insulet Corporation, Medtronic plc., Tandem Diabetes Care, Inc., West Pharmaceutical Services, Inc., and Ypsomed Holding AG.
KEY BENEFITS FOR STAKEHOLDERS
- This report entails a detailed quantitative analysis along with the current global antihypertensive market trends from 2019 to 2026 to identify the prevailing opportunities along with the strategic assessment.
- The market size and estimations are based on a comprehensive analysis of key developments in the industry.
- A qualitative analysis based on innovative products facilitates strategic business planning.
- The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the market
- By Product Type
- Electromechanical Wearable Injectors
- Others
- By Application
- Diabetes
- Cancer
- Others
- By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
- Amgen Inc.
- Becton, Dickinson And Company
- CeQur SA
- Enable Injections, Inc.
- Gerresheimer AG (Sensile Medical AG)
- Insulet Corporation
- Medtronic plc.
- Tandem Diabetes Care, Inc.
- West Pharmaceutical Services, Inc.,
- Ypsomed Holding AG
- E3D Elcam Drug Delivery Devices.
- Subcuject ApS
CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.2.1. List of key players profiled in the report
1.3. Research methodology
1.3.1. Primary research
1.3.2. Secondary research
1.3.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Top player positioning
3.2.1. Top investment pockets
3.3. Key forces shaping ultra large volume wearable injectors industry/market
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Rise in prevalence of chronic disorders which require the use of ultra large volume wearable injectors for treatment
3.4.1.2. Surge in adoption of ultra large volume wearable injectors across the globe
3.4.1.3. Benefits associated with the use of ultra large volume wearable injectors
3.4.2. Restraint
3.4.2.1. High cost of ultra large volume wearable injectors
3.4.3. Opportunity
3.4.3.1. Presence of products in development phase
3.4.4. Impact Analyses
CHAPTER 4: ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY PRODUCT
4.1. Overview
4.1.1. Market size and forecast
4.2. Electromechanical Wearable Injector
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market analysis by country
4.3. Others
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis by country
CHAPTER 5: ULTRA LARGE VOLUME WEARABLE INJECTORS, BY APPLICATION
5.1. Overview
5.1.1. Market size and forecast
5.2. Diabetes
5.2.1. Market size and forecast, by region
5.2.2. Market analysis by country
5.3. Cancer
5.3.1. Market size and forecast, by region
5.3.2. Market analysis by country
5.4. Others
5.4.1. Market size and forecast, by region
5.4.2. Market analysis by country
CHAPTER 6: ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY REGION
6.1. Overview
6.1.1. Market size and forecast
6.2. North America
6.2.1. Key market trends, growth factors, and opportunities
6.2.2. Market size and forecast, by country
6.2.2.1. U.S.
6.2.2.1.1. U.S. ultra large volume wearable injectors market, by product type
6.2.2.1.2. U.S. ultra large volume wearable injectors market, by application
6.2.2.2. Canada
6.2.2.2.1. Canada ultra large volume wearable injectors market, by product type
6.2.2.2.2. Canada ultra large volume wearable injectors market, by application
6.2.2.3. Mexico
6.2.2.3.1. Mexico ultra large volume wearable injectors market, by product type
6.2.2.3.2. Mexico ultra large volume wearable injectors market, by application
6.2.3. North America market size and forecast, by product type
6.2.4. North America market size and forecast, by application
6.3. Europe
6.3.1. Key market trends, growth factors, and opportunities
6.3.2. Market size and forecast, by country
6.3.2.1. Germany
6.3.2.1.1. Germany ultra large volume wearable injectors market, by product type
6.3.2.1.2. Germany ultra large volume wearable injectors market, by application
6.3.2.2. France
6.3.2.2.1. France ultra large volume wearable injectors market, by product type
6.3.2.2.2. France ultra large volume wearable injectors market, by application
6.3.2.3. UK
6.3.2.3.1. UK ultra large volume wearable injectors market, by product type
6.3.2.3.2. UK ultra large volume wearable injectors market, by application
6.3.2.4. Italy
6.3.2.4.1. Italy ultra large volume wearable injectors market, by product type
6.3.2.4.2. Italy ultra large volume wearable injectors market, by application
6.3.2.5. Spain
6.3.2.5.1. Spain ultra large volume wearable injectors market, by product type
6.3.2.5.2. Spain ultra large volume wearable injectors market, by application
6.3.2.6. Rest of Europe
6.3.2.6.1. Rest of Europe ultra large volume wearable injectors market, by product type
6.3.2.6.2. Rest of Europe ultra large volume wearable injectors market, by application
6.3.3. Europe market size and forecast, by product type
6.3.4. Europe market size and forecast, by application
6.4. Asia-Pacific
6.4.1. Key market trends, growth factors, and opportunities
6.4.2. Market size and forecast, by country
6.4.2.1. Japan
6.4.2.1.1. Japan ultra large volume wearable injectors market, by product type
6.4.2.1.2. Japan ultra large volume wearable injectors market, by application
6.4.2.2. China
6.4.2.2.1. China ultra large volume wearable injectors market, by product type
6.4.2.2.2. China ultra large volume wearable injectors market, by application
6.4.2.3. Australia
6.4.2.3.1. Australia ultra large volume wearable injectors market, by product type
6.4.2.3.2. Australia ultra large volume wearable injectors market, by application
6.4.2.4. India
6.4.2.4.1. India ultra large volume wearable injectors market, by product type
6.4.2.4.2. India ultra large volume wearable injectors market, by application
6.4.2.5. South Korea
6.4.2.5.1. South Korea ultra large volume wearable injectors market, by product type
6.4.2.5.2. South Korea ultra large volume wearable injectors market, by application
6.4.2.6. Rest of Asia-Pacific
6.4.2.6.1. Rest of Asia-Pacific ultra large volume wearable injectors market, by product type
6.4.2.6.2. Rest of Asia-Pacific ultra large volume wearable injectors market, by application
6.4.3. Asia-Pacific market size and forecast, by product type
6.4.4. Asia-Pacific market size and forecast, by application
6.5. LAMEA
6.5.1. Key market trends, growth factors, and opportunities
6.5.2. Market size and forecast, by country
6.5.2.1. Brazil
6.5.2.1.1. Brazil ultra large volume wearable injectors market, by product type
6.5.2.1.2. Brazil ultra large volume wearable injectors market, by application
6.5.2.2. Saudi Arabia
6.5.2.2.1. Saudi Arabia ultra large volume wearable injectors market, by product type
6.5.2.2.2. Saudi Arabia ultra large volume wearable injectors market, by application
6.5.2.3. South Africa
6.5.2.3.1. South Africa ultra large volume wearable injectors market, by product type
6.5.2.3.2. South Africa ultra large volume wearable injectors market, by application
6.5.2.4. Rest of LAMEA
6.5.2.4.1. Rest of LAMEA ultra large volume wearable injectors market, by product type
6.5.2.4.2. Rest of LAMEA ultra large volume wearable injectors market, by application
6.5.3. LAMEA market size and forecast, by product type
6.5.4. LAMEA market size and forecast, by application
CHAPTER 7: COMPANY PROFILES
7.1. BECTON, DICKINSON AND COMPANY
7.1.1. Company overview
7.1.2. Company snapshot
7.1.3. Operating business segments
7.1.4. Product portfolio
7.1.5. Business performance
7.2. INSULET CORPORATION
7.2.1. Company overview
7.2.2. Company snapshot
7.2.3. Operating business segments
7.2.4. Product portfolio
7.2.5. Business performance
7.2.6. Key strategic moves and developments
7.3. TANDEM DIABETES CARE, INC.
7.3.1. Company overview
7.3.2. Company snapshot
7.3.3. Operating business segments
7.3.4. Product portfolio
7.3.5. Business performance
7.3.6. Key strategic moves and developments
7.4. YPSOMED HOLDING AG
7.4.1. Company overview
7.4.2. Company snapshot
7.4.3. Operating business segments
7.4.4. Product portfolio
7.4.5. Business performance
7.5. ENABLE INJECTIONS, INC.
7.5.1. Company overview
7.5.2. Company snapshot
7.5.3. Product portfolio
7.5.4. Key strategic moves and developments
7.6. MEDTRONIC PLC.
7.6.1. Company overview
7.6.2. Company snapshot
7.6.3. Operating business segments
7.6.4. Product portfolio
7.6.5. Business performance
7.7. AMGEN INC.
7.7.1. Company overview
7.7.2. Company snapshot
7.7.3. Operating business segments
7.7.4. Product portfolio
7.7.5. Business performance
7.7.6. Key strategic moves and developments
7.8. GERRESHEIMER AG (SENSILE MEDICAL AG)
7.8.1. Company overview
7.8.2. Company snapshot
7.8.3. Operating business segments
7.8.4. Product portfolio
7.8.5. Business performance
7.8.6. Key strategic moves and developments
7.9. WEST PHARMACEUTICAL SERVICES, INC.
7.9.1. Company overview
7.9.2. Company snapshot
7.9.3. Operating business segments
7.9.4. Product portfolio
7.9.5. Business Performance
7.10. CEQUR SA
7.10.1. Company overview
7.10.2. Company snapshot
7.10.3. Product portfolio
1.1. Report description
1.2. Key market segments
1.2.1. List of key players profiled in the report
1.3. Research methodology
1.3.1. Primary research
1.3.2. Secondary research
1.3.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Top player positioning
3.2.1. Top investment pockets
3.3. Key forces shaping ultra large volume wearable injectors industry/market
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Rise in prevalence of chronic disorders which require the use of ultra large volume wearable injectors for treatment
3.4.1.2. Surge in adoption of ultra large volume wearable injectors across the globe
3.4.1.3. Benefits associated with the use of ultra large volume wearable injectors
3.4.2. Restraint
3.4.2.1. High cost of ultra large volume wearable injectors
3.4.3. Opportunity
3.4.3.1. Presence of products in development phase
3.4.4. Impact Analyses
CHAPTER 4: ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY PRODUCT
4.1. Overview
4.1.1. Market size and forecast
4.2. Electromechanical Wearable Injector
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market analysis by country
4.3. Others
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis by country
CHAPTER 5: ULTRA LARGE VOLUME WEARABLE INJECTORS, BY APPLICATION
5.1. Overview
5.1.1. Market size and forecast
5.2. Diabetes
5.2.1. Market size and forecast, by region
5.2.2. Market analysis by country
5.3. Cancer
5.3.1. Market size and forecast, by region
5.3.2. Market analysis by country
5.4. Others
5.4.1. Market size and forecast, by region
5.4.2. Market analysis by country
CHAPTER 6: ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY REGION
6.1. Overview
6.1.1. Market size and forecast
6.2. North America
6.2.1. Key market trends, growth factors, and opportunities
6.2.2. Market size and forecast, by country
6.2.2.1. U.S.
6.2.2.1.1. U.S. ultra large volume wearable injectors market, by product type
6.2.2.1.2. U.S. ultra large volume wearable injectors market, by application
6.2.2.2. Canada
6.2.2.2.1. Canada ultra large volume wearable injectors market, by product type
6.2.2.2.2. Canada ultra large volume wearable injectors market, by application
6.2.2.3. Mexico
6.2.2.3.1. Mexico ultra large volume wearable injectors market, by product type
6.2.2.3.2. Mexico ultra large volume wearable injectors market, by application
6.2.3. North America market size and forecast, by product type
6.2.4. North America market size and forecast, by application
6.3. Europe
6.3.1. Key market trends, growth factors, and opportunities
6.3.2. Market size and forecast, by country
6.3.2.1. Germany
6.3.2.1.1. Germany ultra large volume wearable injectors market, by product type
6.3.2.1.2. Germany ultra large volume wearable injectors market, by application
6.3.2.2. France
6.3.2.2.1. France ultra large volume wearable injectors market, by product type
6.3.2.2.2. France ultra large volume wearable injectors market, by application
6.3.2.3. UK
6.3.2.3.1. UK ultra large volume wearable injectors market, by product type
6.3.2.3.2. UK ultra large volume wearable injectors market, by application
6.3.2.4. Italy
6.3.2.4.1. Italy ultra large volume wearable injectors market, by product type
6.3.2.4.2. Italy ultra large volume wearable injectors market, by application
6.3.2.5. Spain
6.3.2.5.1. Spain ultra large volume wearable injectors market, by product type
6.3.2.5.2. Spain ultra large volume wearable injectors market, by application
6.3.2.6. Rest of Europe
6.3.2.6.1. Rest of Europe ultra large volume wearable injectors market, by product type
6.3.2.6.2. Rest of Europe ultra large volume wearable injectors market, by application
6.3.3. Europe market size and forecast, by product type
6.3.4. Europe market size and forecast, by application
6.4. Asia-Pacific
6.4.1. Key market trends, growth factors, and opportunities
6.4.2. Market size and forecast, by country
6.4.2.1. Japan
6.4.2.1.1. Japan ultra large volume wearable injectors market, by product type
6.4.2.1.2. Japan ultra large volume wearable injectors market, by application
6.4.2.2. China
6.4.2.2.1. China ultra large volume wearable injectors market, by product type
6.4.2.2.2. China ultra large volume wearable injectors market, by application
6.4.2.3. Australia
6.4.2.3.1. Australia ultra large volume wearable injectors market, by product type
6.4.2.3.2. Australia ultra large volume wearable injectors market, by application
6.4.2.4. India
6.4.2.4.1. India ultra large volume wearable injectors market, by product type
6.4.2.4.2. India ultra large volume wearable injectors market, by application
6.4.2.5. South Korea
6.4.2.5.1. South Korea ultra large volume wearable injectors market, by product type
6.4.2.5.2. South Korea ultra large volume wearable injectors market, by application
6.4.2.6. Rest of Asia-Pacific
6.4.2.6.1. Rest of Asia-Pacific ultra large volume wearable injectors market, by product type
6.4.2.6.2. Rest of Asia-Pacific ultra large volume wearable injectors market, by application
6.4.3. Asia-Pacific market size and forecast, by product type
6.4.4. Asia-Pacific market size and forecast, by application
6.5. LAMEA
6.5.1. Key market trends, growth factors, and opportunities
6.5.2. Market size and forecast, by country
6.5.2.1. Brazil
6.5.2.1.1. Brazil ultra large volume wearable injectors market, by product type
6.5.2.1.2. Brazil ultra large volume wearable injectors market, by application
6.5.2.2. Saudi Arabia
6.5.2.2.1. Saudi Arabia ultra large volume wearable injectors market, by product type
6.5.2.2.2. Saudi Arabia ultra large volume wearable injectors market, by application
6.5.2.3. South Africa
6.5.2.3.1. South Africa ultra large volume wearable injectors market, by product type
6.5.2.3.2. South Africa ultra large volume wearable injectors market, by application
6.5.2.4. Rest of LAMEA
6.5.2.4.1. Rest of LAMEA ultra large volume wearable injectors market, by product type
6.5.2.4.2. Rest of LAMEA ultra large volume wearable injectors market, by application
6.5.3. LAMEA market size and forecast, by product type
6.5.4. LAMEA market size and forecast, by application
CHAPTER 7: COMPANY PROFILES
7.1. BECTON, DICKINSON AND COMPANY
7.1.1. Company overview
7.1.2. Company snapshot
7.1.3. Operating business segments
7.1.4. Product portfolio
7.1.5. Business performance
7.2. INSULET CORPORATION
7.2.1. Company overview
7.2.2. Company snapshot
7.2.3. Operating business segments
7.2.4. Product portfolio
7.2.5. Business performance
7.2.6. Key strategic moves and developments
7.3. TANDEM DIABETES CARE, INC.
7.3.1. Company overview
7.3.2. Company snapshot
7.3.3. Operating business segments
7.3.4. Product portfolio
7.3.5. Business performance
7.3.6. Key strategic moves and developments
7.4. YPSOMED HOLDING AG
7.4.1. Company overview
7.4.2. Company snapshot
7.4.3. Operating business segments
7.4.4. Product portfolio
7.4.5. Business performance
7.5. ENABLE INJECTIONS, INC.
7.5.1. Company overview
7.5.2. Company snapshot
7.5.3. Product portfolio
7.5.4. Key strategic moves and developments
7.6. MEDTRONIC PLC.
7.6.1. Company overview
7.6.2. Company snapshot
7.6.3. Operating business segments
7.6.4. Product portfolio
7.6.5. Business performance
7.7. AMGEN INC.
7.7.1. Company overview
7.7.2. Company snapshot
7.7.3. Operating business segments
7.7.4. Product portfolio
7.7.5. Business performance
7.7.6. Key strategic moves and developments
7.8. GERRESHEIMER AG (SENSILE MEDICAL AG)
7.8.1. Company overview
7.8.2. Company snapshot
7.8.3. Operating business segments
7.8.4. Product portfolio
7.8.5. Business performance
7.8.6. Key strategic moves and developments
7.9. WEST PHARMACEUTICAL SERVICES, INC.
7.9.1. Company overview
7.9.2. Company snapshot
7.9.3. Operating business segments
7.9.4. Product portfolio
7.9.5. Business Performance
7.10. CEQUR SA
7.10.1. Company overview
7.10.2. Company snapshot
7.10.3. Product portfolio
LIST OF TABLES
TABLE 01. GLOBAL ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY PRODUCT, 2019-2026 ($MILLION)
TABLE 02. ELECTROMECHANICAL WEARABLE INJECTOR MARKET, BY REGION 2019–2026 ($MILLION)
TABLE 03. ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY REGION, 2018–2026 ($MILLION)
TABLE 04. GLOBAL ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY APPLICATION, 2018-2026 ($MILLION)
TABLE 05. ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET REVENUE FOR DIABETES, BY REGION 2018–2026($MILLION)
TABLE 06. ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET REVENUE FOR CANCER, BY REGION 2018–2026 ($MILLION)
TABLE 07. ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET REVENUE FOR OTHERS, BY REGION 2018–2026 ($MILLION)
TABLE 08. ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY REGION, 2018–2026 ($MILLION)
TABLE 09. NORTH AMERICA ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 10. U.S. ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY PRODUCT TYPE, 2018–2026
TABLE 11. U.S. ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY APPLICATION, 2018–2026
TABLE 12. CANADA ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY PRODUCT TYPE, 2018–2026
TABLE 13. CANADA ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY APPLICATION, 2018–2026
TABLE 14. MEXICO ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY PRODUCT TYPE, 2018–2026
TABLE 15. MEXICO ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY APPLICATION, 2018–2026
TABLE 16. NORTH AMERICA ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY PRODUCT TYPE, 2018–2026
TABLE 17. NORTH AMERICA ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY APPLICATION, 2018–2026
TABLE 18. EUROPE ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 19. GERMANY ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY PRODUCT TYPE, 2018–2026
TABLE 20. GERMANY ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY APPLICATION, 2018–2026
TABLE 21. FRANCE ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY PRODUCT TYPE, 2018–2026
TABLE 22. FRANCE ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY APPLICATION, 2018–2026
TABLE 23. UK ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY PRODUCT TYPE, 2018–2026
TABLE 24. UK ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY APPLICATION, 2018–2026
TABLE 25. ITALY ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY PRODUCT TYPE, 2018–2026
TABLE 26. ITALY ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY APPLICATION, 2018–2026
TABLE 27. SPAIN ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY PRODUCT TYPE, 2018–2026
TABLE 28. SPAIN ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY APPLICATION, 2018–2026
TABLE 29. REST OF EUROPE ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY PRODUCT TYPE, 2018–2026
TABLE 30. REST OF EUROPE ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY APPLICATION, 2018–2026
TABLE 31. EUROPE ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY PRODUCT TYPE, 2018–2026
TABLE 32. EUROPE ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY APPLICATION, 2018–2026
TABLE 33. ASIA-PACIFIC ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 34. JAPAN ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY PRODUCT TYPE, 2018–2026
TABLE 35. JAPAN ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY APPLICATION, 2018–2026
TABLE 36. CHINA ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY PRODUCT TYPE, 2018–2026
TABLE 37. CHINA ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY APPLICATION, 2018–2026
TABLE 38. AUSTRALIA ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY PRODUCT TYPE, 2018–2026
TABLE 39. AUSTRALIA ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY APPLICATION, 2018–2026
TABLE 40. INDIA ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY PRODUCT TYPE, 2018–2026
TABLE 41. INDIA ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY APPLICATION, 2018–2026
TABLE 42. SOUTH KOREA ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY PRODUCT TYPE, 2018–2026
TABLE 43. SOUTH KOREA ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY APPLICATION, 2018–2026
TABLE 44. REST OF ASIA-PACIFIC ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY PRODUCT TYPE, 2018–2026
TABLE 45. REST OF ASIA-PACIFIC ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY APPLICATION, 2018–2026
TABLE 46. ASIA-PACIFIC ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY PRODUCT TYPE, 2018–2026
TABLE 47. ASIA-PACIFIC ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY APPLICATION, 2018–2026
TABLE 48. LAMEA ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 49. BRAZIL ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY PRODUCT TYPE, 2018–2026
TABLE 50. BRAZIL ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY APPLICATION, 2018–2026
TABLE 51. SAUDI ARABIA ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY PRODUCT TYPE, 2018–2026
TABLE 52. SAUDI ARABIA ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY APPLICATION, 2018–2026
TABLE 53. SOUTH AFRICA ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY PRODUCT TYPE, 2018–2026
TABLE 54. SOUTH AFRICA ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY APPLICATION, 2018–2026
TABLE 55. REST OF LAMEA ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY PRODUCT TYPE, 2018–2026
TABLE 56. REST OF LAMEA ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY APPLICATION, 2018–2026
TABLE 57. LAMEA ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY PRODUCT TYPE, 2018–2026
TABLE 58. LAMEA ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY APPLICATION, 2018–2026
TABLE 59. BD: COMPANY SNAPSHOT
TABLE 60. BD: OPERATING SEGMENTS
TABLE 61. BD: PRODUCT PORTFOLIO
TABLE 62. INSULET CORPORATION: COMPANY SNAPSHOT
TABLE 63. INSULET CORPORATION: PRODUCT PORTFOLIO
TABLE 64. TANDEM DIABETES CARE: COMPANY SNAPSHOT
TABLE 65. TANDEM DIABETES CARE: PRODUCT PORTFOLIO
TABLE 66. YPSOMED HOLDING AG: COMPANY SNAPSHOT
TABLE 67. YPSOMED: PRODUCT PORTFOLIO
TABLE 68. ENABLE INJECTIONS: COMPANY SNAPSHOT
TABLE 69. ENABLE INJECTIONS: PRODUCT PORTFOLIO
TABLE 70. MEDTRONIC: COMPANY SNAPSHOT
TABLE 71. MEDTRONIC: OPERATING SEGMENTS
TABLE 72. MEDTRONIC: PRODUCT PORTFOLIO
TABLE 73. AMGEN: COMPANY SNAPSHOT
TABLE 74. AMGEN: PRODUCT PORTFOLIO
TABLE 75. GERRESHEIMER: COMPANY SNAPSHOT
TABLE 76. GERRESHEIMER: OPERATING SEGMENTS
TABLE 77. GERRESHEIMER: PRODUCT PORTFOLIO
TABLE 78. WEST PHARMACEUTICAL SERVICES: COMPANY SNAPSHOT
TABLE 79. WEST PHARMACEUTICAL SERVICES: OPERATING SEGMENTS
TABLE 80. WEST PHARMACEUTICAL SERVICES: PRODUCT PORTFOLIO
TABLE 81. CEQUR: COMPANY SNAPSHOT
TABLE 82. CEQUR: PRODUCT PORTFOLIO
TABLE 01. GLOBAL ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY PRODUCT, 2019-2026 ($MILLION)
TABLE 02. ELECTROMECHANICAL WEARABLE INJECTOR MARKET, BY REGION 2019–2026 ($MILLION)
TABLE 03. ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY REGION, 2018–2026 ($MILLION)
TABLE 04. GLOBAL ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY APPLICATION, 2018-2026 ($MILLION)
TABLE 05. ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET REVENUE FOR DIABETES, BY REGION 2018–2026($MILLION)
TABLE 06. ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET REVENUE FOR CANCER, BY REGION 2018–2026 ($MILLION)
TABLE 07. ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET REVENUE FOR OTHERS, BY REGION 2018–2026 ($MILLION)
TABLE 08. ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY REGION, 2018–2026 ($MILLION)
TABLE 09. NORTH AMERICA ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 10. U.S. ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY PRODUCT TYPE, 2018–2026
TABLE 11. U.S. ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY APPLICATION, 2018–2026
TABLE 12. CANADA ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY PRODUCT TYPE, 2018–2026
TABLE 13. CANADA ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY APPLICATION, 2018–2026
TABLE 14. MEXICO ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY PRODUCT TYPE, 2018–2026
TABLE 15. MEXICO ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY APPLICATION, 2018–2026
TABLE 16. NORTH AMERICA ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY PRODUCT TYPE, 2018–2026
TABLE 17. NORTH AMERICA ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY APPLICATION, 2018–2026
TABLE 18. EUROPE ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 19. GERMANY ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY PRODUCT TYPE, 2018–2026
TABLE 20. GERMANY ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY APPLICATION, 2018–2026
TABLE 21. FRANCE ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY PRODUCT TYPE, 2018–2026
TABLE 22. FRANCE ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY APPLICATION, 2018–2026
TABLE 23. UK ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY PRODUCT TYPE, 2018–2026
TABLE 24. UK ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY APPLICATION, 2018–2026
TABLE 25. ITALY ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY PRODUCT TYPE, 2018–2026
TABLE 26. ITALY ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY APPLICATION, 2018–2026
TABLE 27. SPAIN ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY PRODUCT TYPE, 2018–2026
TABLE 28. SPAIN ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY APPLICATION, 2018–2026
TABLE 29. REST OF EUROPE ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY PRODUCT TYPE, 2018–2026
TABLE 30. REST OF EUROPE ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY APPLICATION, 2018–2026
TABLE 31. EUROPE ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY PRODUCT TYPE, 2018–2026
TABLE 32. EUROPE ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY APPLICATION, 2018–2026
TABLE 33. ASIA-PACIFIC ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 34. JAPAN ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY PRODUCT TYPE, 2018–2026
TABLE 35. JAPAN ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY APPLICATION, 2018–2026
TABLE 36. CHINA ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY PRODUCT TYPE, 2018–2026
TABLE 37. CHINA ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY APPLICATION, 2018–2026
TABLE 38. AUSTRALIA ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY PRODUCT TYPE, 2018–2026
TABLE 39. AUSTRALIA ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY APPLICATION, 2018–2026
TABLE 40. INDIA ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY PRODUCT TYPE, 2018–2026
TABLE 41. INDIA ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY APPLICATION, 2018–2026
TABLE 42. SOUTH KOREA ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY PRODUCT TYPE, 2018–2026
TABLE 43. SOUTH KOREA ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY APPLICATION, 2018–2026
TABLE 44. REST OF ASIA-PACIFIC ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY PRODUCT TYPE, 2018–2026
TABLE 45. REST OF ASIA-PACIFIC ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY APPLICATION, 2018–2026
TABLE 46. ASIA-PACIFIC ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY PRODUCT TYPE, 2018–2026
TABLE 47. ASIA-PACIFIC ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY APPLICATION, 2018–2026
TABLE 48. LAMEA ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 49. BRAZIL ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY PRODUCT TYPE, 2018–2026
TABLE 50. BRAZIL ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY APPLICATION, 2018–2026
TABLE 51. SAUDI ARABIA ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY PRODUCT TYPE, 2018–2026
TABLE 52. SAUDI ARABIA ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY APPLICATION, 2018–2026
TABLE 53. SOUTH AFRICA ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY PRODUCT TYPE, 2018–2026
TABLE 54. SOUTH AFRICA ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY APPLICATION, 2018–2026
TABLE 55. REST OF LAMEA ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY PRODUCT TYPE, 2018–2026
TABLE 56. REST OF LAMEA ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY APPLICATION, 2018–2026
TABLE 57. LAMEA ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY PRODUCT TYPE, 2018–2026
TABLE 58. LAMEA ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY APPLICATION, 2018–2026
TABLE 59. BD: COMPANY SNAPSHOT
TABLE 60. BD: OPERATING SEGMENTS
TABLE 61. BD: PRODUCT PORTFOLIO
TABLE 62. INSULET CORPORATION: COMPANY SNAPSHOT
TABLE 63. INSULET CORPORATION: PRODUCT PORTFOLIO
TABLE 64. TANDEM DIABETES CARE: COMPANY SNAPSHOT
TABLE 65. TANDEM DIABETES CARE: PRODUCT PORTFOLIO
TABLE 66. YPSOMED HOLDING AG: COMPANY SNAPSHOT
TABLE 67. YPSOMED: PRODUCT PORTFOLIO
TABLE 68. ENABLE INJECTIONS: COMPANY SNAPSHOT
TABLE 69. ENABLE INJECTIONS: PRODUCT PORTFOLIO
TABLE 70. MEDTRONIC: COMPANY SNAPSHOT
TABLE 71. MEDTRONIC: OPERATING SEGMENTS
TABLE 72. MEDTRONIC: PRODUCT PORTFOLIO
TABLE 73. AMGEN: COMPANY SNAPSHOT
TABLE 74. AMGEN: PRODUCT PORTFOLIO
TABLE 75. GERRESHEIMER: COMPANY SNAPSHOT
TABLE 76. GERRESHEIMER: OPERATING SEGMENTS
TABLE 77. GERRESHEIMER: PRODUCT PORTFOLIO
TABLE 78. WEST PHARMACEUTICAL SERVICES: COMPANY SNAPSHOT
TABLE 79. WEST PHARMACEUTICAL SERVICES: OPERATING SEGMENTS
TABLE 80. WEST PHARMACEUTICAL SERVICES: PRODUCT PORTFOLIO
TABLE 81. CEQUR: COMPANY SNAPSHOT
TABLE 82. CEQUR: PRODUCT PORTFOLIO
LIST OF FIGURES
FIGURE 01. GLOBAL ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET SEGMENTATION
FIGURE 02. TOP PLAYER POSITIONING, 2018
FIGURE 03. TOP INVESTMENT POCKETS
FIGURE 04. HIGH BARGAINING POWER OF SUPPLIER
FIGURE 05. MODERATE BARGAINING POWER OF BUYERS
FIGURE 06. HIGH THREAT OF SUBSTITUTES
FIGURE 07. MODERATE INTENSITY OF RIVALRY
FIGURE 08. LOW THREAT OF NEW ENTRANT
FIGURE 09. IMPACT ANALYSES, ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET
FIGURE 10. COMPARATIVE SHARE ANALYSIS OF ULTRA LARGE VOLUME WEARABLE INJECTORS MARKETREVENUE FOR ELECTROMECHANICAL WEARABLE INJECTOR, BY COUNTRY, 2018 & 2026 (%)
FIGURE 11. COMPARATIVE SHARE ANALYSIS OF ULTRA LARGE VOLUME WEARABLE INJECTORS MARKETREVENUE FOR OTHERS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 12. COMPARATIVE SHARE ANALYSIS OF ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET REVENUE FOR DIABETES, BY COUNTRY, 2018 & 2026 (%)
FIGURE 13. COMPARATIVE SHARE ANALYSIS OF ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET FOR CANCER, BY COUNTRY, 2018 & 2026 (%)
FIGURE 14. COMPARATIVE SHARE ANALYSIS OF ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET FOR OTHERS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 15. U.S. ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, 2018–2026 ($MILLION)
FIGURE 16. CANADA ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, 2018–2026 ($MILLION)
FIGURE 17. MEXICO ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, 2018–2026 ($MILLION)
FIGURE 18. GERMANY ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, 2018–2026 ($MILLION)
FIGURE 19. FRANCE ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, 2018–2026 ($MILLION)
FIGURE 20. UK ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, 2018–2026 ($MILLION)
FIGURE 21. ITALY ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, 2018–2026 ($MILLION)
FIGURE 22. SPAIN ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, 2018–2026 ($MILLION)
FIGURE 23. REST OF EUROPE ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, 2018–2026 ($MILLION)
FIGURE 24. JAPAN ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, 2018–2026 ($MILLION)
FIGURE 25. CHINA ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, 2018–2026 ($MILLION)
FIGURE 26. AUSTRALIA ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, 2018–2026 ($MILLION)
FIGURE 27. INDIA ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, 2018–2026 ($MILLION)
FIGURE 28. SOUTH KOREA ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, 2018–2026 ($MILLION)
FIGURE 29. REST OF ASIA-PACIFIC ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, 2018–2026 ($MILLION)
FIGURE 30. BRAZIL ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, 2018–2026 ($MILLION)
FIGURE 31. SAUDI ARABIA ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, 2018–2026 ($MILLION)
FIGURE 32. SOUTH AFRICA ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, 2018–2026 ($MILLION)
FIGURE 33. REST OF LAMEA ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, 2018–2026 ($MILLION)
FIGURE 34. BD: NET SALES, 2017–2019 ($MILLION)
FIGURE 35. BD: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 36. BD: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 37. INSULET CORPORATION: NET SALES, 2016–2018 ($MILLION)
FIGURE 38. INSULET CORPORATION: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 39. TANDEM DIABETES CARE: NET SALES, 2015–2017 ($MILLION)
FIGURE 40. YPSOMED: NET SALES, 2017–2019 ($MILLION)
FIGURE 41. YPSOMED: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 42. MEDTRONIC PLC: NET SALES, 2017–2019 ($MILLION)
FIGURE 43. MEDTRONIC: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 44. MEDTRONIC: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 45. AMGEN: NET SALES, 2016–2018 ($MILLION)
FIGURE 46. AMGEN: REVENUE SHARE BY GEOGRAPHY, 2018 (%)
FIGURE 47. GERRESHEIMER: NET SALES, 2016–2018 ($MILLION)
FIGURE 48. GERRESHEIMER: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 49. WEST PHARMACEUTICAL SERVICES: NET SALES, 2016–2018 ($MILLION)
FIGURE 50. WEST PHARMACEUTICAL SERVICES: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 51. WEST PHARMACEUTICAL SERVICES: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 01. GLOBAL ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET SEGMENTATION
FIGURE 02. TOP PLAYER POSITIONING, 2018
FIGURE 03. TOP INVESTMENT POCKETS
FIGURE 04. HIGH BARGAINING POWER OF SUPPLIER
FIGURE 05. MODERATE BARGAINING POWER OF BUYERS
FIGURE 06. HIGH THREAT OF SUBSTITUTES
FIGURE 07. MODERATE INTENSITY OF RIVALRY
FIGURE 08. LOW THREAT OF NEW ENTRANT
FIGURE 09. IMPACT ANALYSES, ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET
FIGURE 10. COMPARATIVE SHARE ANALYSIS OF ULTRA LARGE VOLUME WEARABLE INJECTORS MARKETREVENUE FOR ELECTROMECHANICAL WEARABLE INJECTOR, BY COUNTRY, 2018 & 2026 (%)
FIGURE 11. COMPARATIVE SHARE ANALYSIS OF ULTRA LARGE VOLUME WEARABLE INJECTORS MARKETREVENUE FOR OTHERS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 12. COMPARATIVE SHARE ANALYSIS OF ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET REVENUE FOR DIABETES, BY COUNTRY, 2018 & 2026 (%)
FIGURE 13. COMPARATIVE SHARE ANALYSIS OF ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET FOR CANCER, BY COUNTRY, 2018 & 2026 (%)
FIGURE 14. COMPARATIVE SHARE ANALYSIS OF ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET FOR OTHERS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 15. U.S. ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, 2018–2026 ($MILLION)
FIGURE 16. CANADA ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, 2018–2026 ($MILLION)
FIGURE 17. MEXICO ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, 2018–2026 ($MILLION)
FIGURE 18. GERMANY ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, 2018–2026 ($MILLION)
FIGURE 19. FRANCE ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, 2018–2026 ($MILLION)
FIGURE 20. UK ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, 2018–2026 ($MILLION)
FIGURE 21. ITALY ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, 2018–2026 ($MILLION)
FIGURE 22. SPAIN ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, 2018–2026 ($MILLION)
FIGURE 23. REST OF EUROPE ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, 2018–2026 ($MILLION)
FIGURE 24. JAPAN ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, 2018–2026 ($MILLION)
FIGURE 25. CHINA ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, 2018–2026 ($MILLION)
FIGURE 26. AUSTRALIA ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, 2018–2026 ($MILLION)
FIGURE 27. INDIA ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, 2018–2026 ($MILLION)
FIGURE 28. SOUTH KOREA ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, 2018–2026 ($MILLION)
FIGURE 29. REST OF ASIA-PACIFIC ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, 2018–2026 ($MILLION)
FIGURE 30. BRAZIL ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, 2018–2026 ($MILLION)
FIGURE 31. SAUDI ARABIA ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, 2018–2026 ($MILLION)
FIGURE 32. SOUTH AFRICA ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, 2018–2026 ($MILLION)
FIGURE 33. REST OF LAMEA ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, 2018–2026 ($MILLION)
FIGURE 34. BD: NET SALES, 2017–2019 ($MILLION)
FIGURE 35. BD: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 36. BD: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 37. INSULET CORPORATION: NET SALES, 2016–2018 ($MILLION)
FIGURE 38. INSULET CORPORATION: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 39. TANDEM DIABETES CARE: NET SALES, 2015–2017 ($MILLION)
FIGURE 40. YPSOMED: NET SALES, 2017–2019 ($MILLION)
FIGURE 41. YPSOMED: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 42. MEDTRONIC PLC: NET SALES, 2017–2019 ($MILLION)
FIGURE 43. MEDTRONIC: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 44. MEDTRONIC: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 45. AMGEN: NET SALES, 2016–2018 ($MILLION)
FIGURE 46. AMGEN: REVENUE SHARE BY GEOGRAPHY, 2018 (%)
FIGURE 47. GERRESHEIMER: NET SALES, 2016–2018 ($MILLION)
FIGURE 48. GERRESHEIMER: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 49. WEST PHARMACEUTICAL SERVICES: NET SALES, 2016–2018 ($MILLION)
FIGURE 50. WEST PHARMACEUTICAL SERVICES: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 51. WEST PHARMACEUTICAL SERVICES: REVENUE SHARE BY REGION, 2018 (%)
